Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The variable expression of autism over the lifespan is likely to lead to different symptoms and support requirements, and to distinct responses to pharmacotherapy treatment, in older patients compared to children. This systematic review considers the effectiveness of pharmacological treatment in managing autism spectrum disorder in adolescents and adults. Following a comprehensive search of literature published in English from 1980, methodological criteria were applied to identify studies designed to reliably assess treatment effectiveness. Only five double-blind, randomized controlled trials were eligible for appraisal. All had small sample sizes (mean = 30) and brief treatment duration of no more than 12 weeks. The paucity of trials and their methodological limitations means that there is only preliminary evidence about the short-term effectiveness of a few drug treatments for this age group. There was also a lack of reliable data reported on drug safety profiles. Methodological challenges and directions for future research are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VOLKMAR, F. R., & NELSON, D. S. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199001000-00020 · Cited by 439
Rapin, I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370206 · Cited by 319
Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602762599853 · Cited by 123
Cited by
Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
Nabavi, S. F., Braidy, N., Gortzi, O., Sobarzo-Sanchez, E., Daglia, M., Skalicka-Woźniak, K., & Nabavi, S. M. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.09.002 · Cited by 480
Autism spectrum disorder in adults: diagnosis, management, and health services development
Murphy, C., Wilson, C. E., Robertson, D. M., Ecker, C., Daly, E. M., Hammond, N., Galanopoulos, A., Dud, I., Murphy, D., & McAlonan, G. M. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65455 · Cited by 261
Mast cells, brain inflammation and autism
Theoharides, T. C., Stewart, J. M., Panagiotidou, S., & Melamed, I. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.086 · Cited by 138
An endocannabinoid-regulated basolateral amygdala–nucleus accumbens circuit modulates sociability
Folkes, O. M., Báldi, R., Kondev, V., Marcus, D. J., Hartley, N. D., Turner, B. D., Ayers, J. K., Baechle, J. J., Misra, M. P., Altemus, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131752 · Cited by 119
‘The line between intervention and abuse’ – autism and applied behaviour analysis
Kirkham, P. (2017) · History of the Human Sciences · doi:10.1177/0952695117702571 · Cited by 85
Metadata
- Authors
- Broadstock, M., Doughty, C., & Eggleston, M.
- Venue
- Autism
- Publisher
- SAGE Publications
- Published
- 2007-07
- Volume
- 11
- Issue
- 4
- Pages
- 335-348
- ISSN
- 1362-3613 (ISSN-L)
- 1461-7005
- OpenAlex
- W2104671744
- Cited by
- 72
- References
- 3
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder. https://app.cochat.ai/papers/10.1177/1362361307078132
- The paper
- Broadstock, M., Doughty, C., & Eggleston, M. (2007). Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder. Autism. https://doi.org/10.1177/1362361307078132
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.